pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

1,599 catalysts · 3,301 8k filing · 1,080 grant · 1,000 device adverse event · 579 earnings · 519 approval · 408 device 510k

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 0 catalysts2026-08-13: 0 catalysts2026-08-14: 17 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
type: grant×type: approval×from 2026-03-04×clear all
type
  • 8k filing3,301
  • grant1,080
  • device adverse event1,000
  • earnings579
  • approval519
  • device 510k408
device pma
236
  • phase 2 completion172
  • drug shortage133
  • recall121
  • therapy area

    no tagged catalysts yet

    Week of Mar 2, 2026

    50
    ›Mar 4, 2026approval164d agoBAL (DIMERCAPROL) — FDA approvalAkorn Operating Company LLC (Inactive)

    Sponsor: PROVEPHARM SAS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 4, 2026approval164d agoROCURONIUM BROMIDE — FDA approvalROCURONIUM BROMIDE

    Sponsor: ASPIRO. Form: INJECTABLE. Route: INJECTION

    full page →ROCURONIUM BROMIDE →fda approvals ↗
    ›Mar 4, 2026approval164d agoEMTRICITABINE, RILPIVIRINE AND TENOFOVIR DISOPROXIL FUMARATE (EMTRICITABINE) — FDA approvalHetero USA Inc

    Sponsor: LAURUS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 4, 2026approval164d agoCALCITONIN-SALMON (CALCITONIN SALMON) — FDA approvalZydus Therapeutics Inc

    Sponsor: ZYDUS PHARMS. Form: INJECTABLE. Route: INJECTION

    full page →fda approvals ↗
    ›Mar 4, 2026approval164d agoDESIPRAMINE HYDROCHLORIDE — FDA approvalAmneal Pharmaceuticals, Inc.

    Sponsor: AMNEAL PHARMS CO. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 4, 2026approval164d agoGLIPIZIDE — FDA approvalGraviti Pharmaceuticals Inc

    Sponsor: GRAVITI PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 4, 2026grant164d agoGORDON RESEARCH CONFERENCES — 2026 Single-Cell Cancer Biology Gordon Research Conference and Gordon Researc...

    CA grant. $10,000. PI: Ken Chen

    full page →nih reporter ↗
    ›Mar 4, 2026grant164d agoALBERT EINSTEIN COLLEGE OF MEDICINE — Scalable imaging approach to measure muscle bioenergetics in CKD.Albert Einstein College of Medicine

    AR grant. $556,651. PI: Matthew K Abramowitz

    full page →nih reporter ↗
    ›Mar 4, 2026grant164d agoUNIVERSITY OF ALABAMA AT BIRMINGHAM — 10-Year Follow-Up of the Medical Optimization and Management of Pregnancies w...

    DK grant. $1,934,914. PI: Ashley Nicole Battarbee

    full page →nih reporter ↗
    ›Mar 4, 2026grant164d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Neocortical-hippocampal coordination and plasticity in sleep-dependent memory...

    NS grant. $419,920. PI: SARA J ATON

    full page →nih reporter ↗
    ›Mar 5, 2026approval163d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalPrinston Pharmaceutical Inc

    Sponsor: TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 5, 2026approval163d agoCHOLESTYRAMINE — FDA approvalCHOLESTYRAMINE

    Sponsor: MICRO LABS. Form: POWDER. Route: ORAL

    full page →CHOLESTYRAMINE →fda approvals ↗
    ›Mar 5, 2026approval163d agoIBUPROFEN — FDA approvalMidol

    Sponsor: RUBICON RESEARCH. Form: SUSPENSION. Route: ORAL

    full page →Midol →fda approvals ↗
    ›Mar 5, 2026approval163d agoTECVAYLI (TECLISTAMAB-CQYV) — FDA approvalteclistamab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →teclistamab →fda approvals ↗
    ›Mar 5, 2026approval163d agoTALVEY (TALQUETAMAB-TGVS) — FDA approvaltalquetamab

    Sponsor: JANSSEN BIOTECH. Form: INJECTABLE. Route: INJECTION

    full page →talquetamab →fda approvals ↗
    ›Mar 5, 2026approval163d agoOLANZAPINE — FDA approvalTEVA PHARMACEUTICAL INDUSTRIES LTD

    Sponsor: ANTHEA PHARMA. Form: POWDER. Route: INTRAMUSCULAR

    full page →fda approvals ↗
    ›Mar 5, 2026approval163d agoAPREPITANT — FDA approvalAPREPITANT

    Sponsor: MYLAN. Form: EMULSION. Route: INTRAVENOUS

    full page →APREPITANT →fda approvals ↗
    ›Mar 5, 2026approval163d agoCHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE) — FDA approvalAlgoTherapeutix SAS

    Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 5, 2026approval163d agoCHLORDIAZEPOXIDE AND AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE) — FDA approvalAlgoTherapeutix SAS

    Sponsor: TP ANDA HOLDINGS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Mar 5, 2026approval163d agoXYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE) — FDA approvalSanofi

    Sponsor: CHATTEM SANOFI. Form: SOLUTION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 5, 2026approval163d agoKEFLEX (CEPHALEXIN) — FDA approvalBelcher Pharmaceuticals LLC

    Sponsor: PRAGMA. Form: FOR SUSPENSION. Route: ORAL

    full page →fda approvals ↗
    ›Mar 5, 2026approval163d agoIRBESARTAN AND HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE) — FDA approvalALDACTAZIDE

    Sponsor: PRINSTON INC. Form: TABLET. Route: ORAL

    full page →ALDACTAZIDE →fda approvals ↗
    ›Mar 5, 2026approval163d agoERLEADA (APALUTAMIDE) — FDA approvalapalutamide

    Sponsor: JANSSEN BIOTECH. Form: TABLET. Route: ORAL

    full page →apalutamide →fda approvals ↗
    ›Mar 5, 2026approval163d agoPAROXETINE HYDROCHLORIDE — FDA approvalPAROXETINE HYDROCHLORIDE

    Sponsor: ANNORA PHARMA. Form: SUSPENSION. Route: ORAL

    full page →PAROXETINE HYDROCHLORIDE →fda approvals ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF MICHIGAN AT ANN ARBOR — Reprogramming cells for repair of chronic wounds

    GM grant. $409,941. PI: Aaron Harvey Morris

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoSANFORD RESEARCH NORTH — Identifying the Specific Reward Processes Underlying the Maintenance of Binge...

    MH grant. $442,750. PI: Lauren Marie Schaefer

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Contributions of Myeloid Peroxisomes to Inflammation in HeartNorthwestern University

    HL grant. $44,751. PI: Abhishek Vijay Thakkar

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Core C: Animal Model Core

    CA grant. $550,210. PI: Shawn Hingtgen

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF TENNESSEE KNOXVILLE — Pioneering Mass Spectrometry-Based Footprinting to Reveal Human Membrane Prot...

    GM grant. $406,112. PI: Jie Sun

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoJOHNS HOPKINS UNIVERSITY — Biophysical theory for condensate dynamics: advancing beyond minimal modelsJohns Hopkins University

    GM grant. $406,026. PI: Yaojun Zhang

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoSTATE UNIVERSITY NEW YORK STONY BROOK — Deciphering the regulatory mechanisms of extracellular particle-mediated sign...

    GM grant. $432,569. PI: Simou Sun

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF NOTRE DAME — Autonomous Hybrid Bioprinting of Hierarchical Perfusable Vascularized Liver T...

    EB grant. $662,737. PI: Yanliang Zhang

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF HOUSTON — Epidemiology, etiology, and pathways to DLD: The role of late talking in ling...

    DC grant. $2,387,184. PI: JACK M FLETCHER

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoMEDICAL UNIVERSITY OF SOUTH CAROLINA — Adapting Written Exposure Therapy for Adolescents with Posttraumatic Stress D...

    MH grant. $208,794. PI: Emily Lauren Tilstra-Ferrell

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoKENNESAW STATE UNIVERSITY — Workflow Optimization for School-based Preventive Oral Health Services Delivery

    DE grant. $555,081. PI: Christina Scherrer

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoBAYLOR COLLEGE OF MEDICINE — Ethics and Decision-Making in Translational Neurological Device ResearchBaylor College of Medicine

    MH grant. $445,816. PI: Jennifer Blumenthal-Barby

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF WYOMING — Cell Fusion and Gene Expression in the C. elegans Epidermis

    GM grant. $123,687. PI: Owen Funk

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC — Longitudinal Pet Imaging Of Antipsychotic Binding To The Dopamine-3 Receptor ...

    MH grant. $843,322. PI: Ragy Ramsis Girgis

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF PENNSYLVANIA — Training Leaders to Improve Outcomes in Older Adults Using Advanced MethodsUniversity of Pennsylvania

    AG grant. $214,223. PI: Robert Edward Burke

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF COLORADO — The Menses Study: Menstrual blood as a novel target-tissue biomatrix for chem...

    OD grant. $434,110. PI: Jenni Shearston

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoNEW YORK UNIVERSITY — Neural circuit mechanisms of dynamic learning ratesNew York University

    MH grant. $710,563. PI: Christine M Constantinople

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF CALIFORNIA LOS ANGELES — Mapping the Mechanome: A Systems-level Understanding of Mechanical Mediators ...University of California Los Angeles

    GM grant. $433,125. PI: Amy C Rowat

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoBOSTON UNIVERSITY (CHARLES RIVER CAMPUS) — Advancing targeted delivery of intracellular protein therapeutics

    GM grant. $449,625. PI: Samagya Banskota

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF IOWA — Role of Notch Pathway in the Pathogenesis of Chronic PancreatitisUniversity of Iowa

    DK grant. $655,482. PI: VIKAS DUDEJA

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoICAHN SCHOOL OF MEDICINE AT MOUNT SINAI — Controlling epilepsy symptoms with precisely timed inhibition and circuit edi...

    NS grant. $75,880. PI: Christopher David Adam

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUT SOUTHWESTERN MEDICAL CENTER — The roles of Rett Syndrome protein MECP2 at gene regulatory elements

    MH grant. $641,828. PI: Hume Akahori Stroud

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoRUTGERS BIOMEDICAL AND HEALTH SCIENCES — Loneliness and inflammatory markers as biopsychosocial pathways to AD/ADRD: A...

    AG grant. $121,239. PI: Mara Getz Sheftel

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoCINCINNATI CHILDRENS HOSP MED CTR — Impact of Circadian Misalignment for Adolescents with ADHD: Observational and...

    MH grant. $820,196. PI: Stephen P Becker

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoUNIVERSITY OF IOWA — Investigating single cell transcriptomics and epigenetic regulation to enable...University of Iowa

    MH grant. $779,797. PI: Rainbo Hultman

    full page →nih reporter ↗
    ›Mar 5, 2026grant163d agoHENRY M. JACKSON FDN FOR THE ADV MIL/MED — Neural Plasticity and Myelin Dynamics after Amputation

    NS grant. $555,265. PI: Emily Rose Petrus

    full page →nih reporter ↗
    ← prev
    page 1 of 32
    next →
    $AMRX17.27-2.21%
    $TEVA36.52-0.60%
    $SNY43.78+0.16%